Phylonix to present at 2009 Society of Toxicology Annual Meeting

March 10, 2009

Cambridge, MA - March 10, 2009 - Phylonix Pharmaceuticals, Inc., the leading contract research organization for preclinical testing in zebrafish, will present data about the company's in vivo zebrafish-based assays at the 48th Society of Toxicology (SOT) Annual Meeting being held March 15-19 at the Baltimore Convention Center in Baltimore, Maryland. A podium presentation will be presented at SOT on Tuesday, March 17 and two posters will be presented on Monday, March 16 and Tuesday, March 17, respectively.

Podium Presentation
"Assessment of Ototoxicity and Otoprotection in a Zebrafish Hair Cell Model"

Tuesday, March 17, 10:36 am - 10:59 am, Room 308

Poster Presentations

"Assessment of Drug Induced Cardiotoxicity in Transparent Zebrafish"
Monday, March 16, 1:00 pm - 4:30 pm
390 Poster / Board 207

"Zebrafish: A Predictive Model for Assessing P-Glycoprotein Inhibitors"
Tuesday, March 17, 9:00 am-12:30 pm
983 Poster / Board 534

The company is exhibiting at ToxExpo in Booth 2950 from Monday, March 16 through Wednesday, March 18; and is also sponsoring a lunch hour workshop, "Zebrafish: A Predictive Model for Assessing Safety and Toxicity," on Monday, March 16 from 12:15 pm-1:15 pm. Space is limited and reservations are required. Please contact Kristine.karklins@phylonix.com or 617-441-6700 x312 to reserve your seat or for more information.
-end-
About Phylonix

Phylonix, located in Cambridge, MA, is a Contract Research Organization developing and marketing patented, in vivo zebrafish-based assays, eZ-Screens, for assessing drug candidates for cancers, central nervous system disorders, cardiovascular diseases, apoptosis, and organ toxicity. The company also offers services for target identification and validation. Partnerships are available for these services as well as for drug repositioning candidates that fail clinical trials for an initial indication. Services are tailored for several industry sectors including: agrochemicals, biotechnology, pharmaceuticals, nutraceuticals, environmental and other government agencies, as well as general safety liability.

For information on licensing options contact Edward O'Lear, Vice President of Finance and Business Development at ed.olear@phylonix.com or 617-441-6700 ext 302.

Phylonix Pharmaceuticals

Related Zebrafish Articles from Brightsurf:

Zebrafish embryos help prove what happens to nanoparticles in the blood
What happens to the nanoparticles when they are injected into the bloodstream, for example, to destroy solid tumours?

Social experiences impact zebrafish from an early age
Study in zebrafish demonstrates that early social experiences have an effect on the behaviour of the fish even at an age when they are still not considered ''social''.

How zebrafish maintain efficient and fair foraging behaviours
New insight on how zebrafish achieve near-optimal foraging efficiency and fairness among groups has been published today in the open-access journal eLife.

How the zebrafish got its stripes
Animal patterns are a source of endless fascination, and now researchers at the University Bath have worked out how zebrafish develop their stripes.

Extraordinary regeneration of neurons in zebrafish
Biologists from the University of Bayreuth have discovered a uniquely rapid form of regeneration in injured neurons and their function in the central nervous system of zebrafish.

Zebrafish teach researchers more about atrial fibrillation
Genetic research in zebrafish at the University of Copenhagen has surprised the researchers behind the study.

How decisions unfold in a zebrafish brain
Researchers were able to track the activity of each neuron in the entire brain of zebrafish larvae and reconstruct the unfolding of neuronal events as the animals repeatedly made 'left or right' choices in a behavioral experiment.

'Census' in the zebrafish's brain
Dresden scientists have succeeded in determining the number and type of newly formed neurons in zebrafish; practically conducting a 'census' in their brains.

Zebrafish 'avatars' can help decide who should receive radiotherapy treatment
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients.

Special cells contribute to regenerate the heart in Zebrafish
It is already known that zebrafish can flexibly regenerate their hearts after injury.

Read More: Zebrafish News and Zebrafish Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.